Actinium Pharmaceuticals (ATNM)
(Delayed Data from AMEX)
$7.55 USD
-0.32 (-4.07%)
Updated Jun 20, 2024 04:00 PM ET
After-Market: $7.58 +0.03 (0.40%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Brokerage Reports
Actinium Pharmaceuticals, Inc. [ATNM]
Reports for Purchase
Showing records 61 - 80 ( 94 total )
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
We are initiating coverage with a Buy rating and $3 price target.
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
We are dropping coverage of ATNM shares due to the departure of the covering analyst.
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Healthcare -New Leukemia Approvals - Their Implications
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Dropping Coverage
Provider: H.C. Wainwright & Co., Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Healthcare - ORD-ARN-JFK: Crossing Our Onco Radar
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Antibody, Radiolabel, Action! Resuming with Buy and $6 PT
Provider: Roth Capital Partners, Inc.